Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma
Article in Cellular Oncology (February 2024)
The most recent citing publications are shown below. View all 205 publications that cite this research output on Dimensions.
Article in Cellular Oncology (February 2024)
Article in International Journal of Clinical Oncology (December 2023)
Article in Cureus (November 2023)